{
    "code": "02019595",
    "time": "2015-07-05 02:18:00",
    "許可證字號": "衛署藥輸字第019595號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/11\/14",
    "發證日期": "81\/11\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201959500",
    "中文品名": "守肺佳氣管吸入懸浮液",
    "英文品名": "SURVANTA 200MG\/8ML\/VIAL INTRATRACHEAL SUSPENSION",
    "適應症": "預防和治療早產兒之呼吸窘迫症（ＲＥＳＰＩＲＡＴＩＯＮ　　　　　　　　ＤＩＳＴＲＥＳＳ　ＳＹＮＤＲＯＭＥ）。",
    "劑型": "403鼻用吸入劑",
    "包裝": "100支以下小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "PHOSPHOLIPID, BOVINE LUNG LIPIDS, DIPALMITOYL PHOSPHATIDYLCHOLINE, DISATURATED PHOSPHATIDYLCHOLINE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "6401101591  瑞士商艾伯維藥品有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號及51號15樓",
    "主製造廠": {
        "製造廠名稱": "M460799000  ABBVIE INC.",
        "製造廠廠址": "1401 SHERIDAN RD., NORTH CHICAGO, IL 60064, U.S.A.",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [

    ],
    "藥物辨識詳細資料": [

    ],
    "藥物辨識外觀圖片": [

    ]
}